A retrospective study assessing association between ibrutinib treatment and hypertension
Latest Information Update: 09 Jul 2021
At a glance
- Drugs Ibrutinib (Primary) ; Bendamustine; Cyclophosphamide; Fludarabine; Lenalidomide; Rituximab
- Indications B-cell leukaemia; B-cell lymphoma; B-cell prolymphocytic leukaemia
- Focus Adverse reactions
- 09 Jul 2021 New trial record
- 01 Jul 2021 Results published in the Heart